DeepMed Research

Norwegian University of Science & Technology

🇳🇴Norway

Country: 🇳🇴Norway

Ownership: Private

Established: 1996-01-01

Employees: -

Market Cap: -

Website: http://www.ntnu.no

Clinical Trials

The Immune System and Psychiatric Disorders

Completed

Conditions: Stress Disorders, Traumatic
Depressive Disorder
Bipolar Disorder
Personality Disorders
Schizophrenia
Psychotic Disorders

First Posted Date: 2005-09-16

Last Posted Date: 2017-03-13

Lead Sponsor: Norwegian University of Science and Technology

Target Recruit Count: 1400

Registration Number: NCT00184418

Locations: 🇳🇴
St Olavs Hospital, Department of Psychiatry, Østmarka Hospital, Trondheim, Middle Norway, Norway

On Demand Treatment of Reflux Disease

Phase 4

Completed

Conditions: Gastroesophageal Reflux

Interventions: Drug: Aflurax
Drug: esomeprazole

First Posted Date: 2005-09-16

Last Posted Date: 2011-08-09

Lead Sponsor: Norwegian University of Science and Technology

Target Recruit Count: 82

Registration Number: NCT00184522

Locations: 🇳🇴
Gjøvik Specialist Centre, Gjøvik, Norway
🇳🇴
Sykehuset Innlandet HF, Hamar, Hamar, Norway
🇳🇴
Sykehuset Innlandet HF, Gjøvik, Gjøvik, Norway

and more 6 locations

RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo

Phase 4

Completed

Conditions: Phobic Disorders

Interventions: Drug: Seroxat, Cognitive therapy, Seroxat+ cognitive therapy

First Posted Date: 2005-09-16

Last Posted Date: 2018-08-27

Lead Sponsor: Norwegian University of Science and Technology

Target Recruit Count: 86

Registration Number: NCT00184106

Locations: 🇳🇴
Dept. of Psychology, NTNU, Trondheim, Dragvoll, Norway

Treatment for Cubital Tunnel Syndrome

Not Applicable

Completed

Conditions: Cubital Tunnel Syndrome

First Posted Date: 2005-09-16

Last Posted Date: 2017-08-22

Lead Sponsor: Norwegian University of Science and Technology

Target Recruit Count: 81

Registration Number: NCT00184158

Locations: 🇳🇴
St Olavs Hospital, Trondheim, Norway

Secured Internet-mediated Psychotherapy With Psychiatry Patients

Completed

Conditions: Psychiatric Disorders

First Posted Date: 2005-09-16

Last Posted Date: 2017-02-09

Lead Sponsor: Norwegian University of Science and Technology

Target Recruit Count: 6

Registration Number: NCT00184340

Locations: 🇳🇴
Child Psychiatry Department, St. Olav Hospital, Orkdal Site, Orkanger, Norway
🇳🇴
Child Psychiatry Department, Levanger Hospital, Levanger, Norway

Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis

Terminated

Conditions: Plaque Psoriasis

First Posted Date: 2005-09-16

Last Posted Date: 2012-01-19

Lead Sponsor: Norwegian University of Science and Technology

Target Recruit Count: 96

Registration Number: NCT00184366

Locations: 🇳🇴
Dep of dermatology, St Olavs Hospital, Trondheim, Norway

Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.

Withdrawn

Conditions: Neoplasm Metastasis
Lung Neoplasms
Breast Neoplasms
Melanoma

First Posted Date: 2005-09-16

Last Posted Date: 2011-11-02

Lead Sponsor: Norwegian University of Science and Technology

Registration Number: NCT00184288

Locations: 🇳🇴
Norwegian University of Science and Technology, Faculty of Medicine, Trondheim, Norway

Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.

Completed

Conditions: Neoplasm Metastases

First Posted Date: 2005-09-16

Last Posted Date: 2011-10-21

Lead Sponsor: Norwegian University of Science and Technology

Target Recruit Count: 19

Registration Number: NCT00184353

Locations: 🇳🇴
Norwegian University of Science and Technology, Trondheim, Norway

Does Intensive Task Specific Training Improve Balance After Acute Stroke?

Not Applicable

Completed

Conditions: Cerebrovascular Accident

Interventions: Behavioral: Physical therapy technique and exercises

First Posted Date: 2005-09-16

Last Posted Date: 2011-10-18

Lead Sponsor: Norwegian University of Science and Technology

Target Recruit Count: 62

Registration Number: NCT00184431

Locations: 🇳🇴
Norwegian University of Science and Technology, Trondheim, Norway

Prophylactic Treatment of Episodic Cluster Headache

Phase 2

Completed

Conditions: Cluster Headache

Interventions: Drug: placebo
Drug: candesartan cilexetil

First Posted Date: 2005-09-16

Last Posted Date: 2013-04-23

Lead Sponsor: Norwegian University of Science and Technology

Target Recruit Count: 40

Registration Number: NCT00184587

Locations: 🇳🇴
Norwegian National Headache Centre St.Olavs Hospital, Trondheim, Norway

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy